VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
MVST
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
MVSTMicrovast Holdings, Inc.
$0.63$209M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksMVSTBalance Sheet

Microvast Holdings, Inc. (MVST) Balance Sheet

8Y historyFree accessUpdated daily

Leverage has improved materially with total debt reduced to $193.0M from $429.1M and debt-to-equity cut to 0.36, yet the 1.09 current ratio against $409.1M of liabilities and declining deferred revenue of $31.7M indicate the liquidity cushion stays thin.

Income StatementBalance SheetCash FlowRatios

MVST Balance Sheet

Annual statement

MVST Balance Sheet

Microvast Holdings, Inc. (MVST) balance sheet — 8-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18
Total Current Assets374.92M448.72M428.03M425.61M545.07M706.61M189.32M396.37K17.52K
Cash & Short-Term Investments143.09M104.96M73.01M87.65M256.49M480.93M21.5M29.47M17.5K
Cash Only143.09M104.96M73.01M82.02M231.42M480.93M21.5M27.98M17.5K
Short-Term Investments0005.63M25.07M001.49M0
Accounts Receivable122.52M169.96M146.01M177.48M124.22M104.25M100.09M67.64M0
Days Sales Outstanding140.72145.11140.32211.28221.72250.39339.78323.01-
Inventory93.59M89.41M143.33M155.55M84.25M53.42M44.97M59.16M0
Days Inventory Outstanding134.26119.59201.02227.66157.36100.14181.61281.66-
Other Current Assets15.73M84.39M56.47M950K70.73M55.18M19.7M-155.95M0
Total Non-Current Assets577.27M556.73M523.84M671.13M439.89M288.69M215.19M280.1M83.67K
Property, Plant & Equipment543.45M525.39M495.82M640.17M351.51M253.06M198.02M191.32M0
Fixed Asset Turnover0.69x0.81x0.77x0.48x0.58x0.60x0.54x0.40x-
Goodwill000000000
Intangible Assets13.74M2.18M13.98M15.12M14.28M15.89M16.28M16.08M0
Long-Term Investments02.58M22K6.17M465K00280.1M0
Other Non-Current Assets14.65M21.14M14.02M21.64M74.11M19.74M890K1.57M83.67K
Total Assets952.19M1.01B951.87M1.1B984.96M995.29M404.51M280.5M101.2K
Asset Turnover0.37x0.43x0.40x0.28x0.21x0.15x0.27x0.27x1721.69x
Asset Growth %0.14%5.63%-13.21%11.35%-1.04%146.05%44.21%--
Total Current Liabilities343.75M488.34M330.15M403.41M252.41M175.59M183.63M195.8M75.79K
Accounts Payable62.64M47M64.94M112.62M44.98M40.41M42.01M35.58M0
Days Payables Outstanding71.5462.8791.08164.8284.0275.74169.65169.4-
Short-Term Debt161.12M312.3M122.42M98.77M85.84M74.25M77.88M120.89M75.34K
Deferred Revenue (Current)100.53M41.47M43.68M43.09M54.21M1.53M2.45M-156.47M0
Other Current Liabilities75.04M20.29M23.77M137.78M60.07M31.56M8.26M195.8M450
Current Ratio1.09x0.92x1.30x1.06x2.16x4.02x1.03x0.00x0.23x
Quick Ratio0.82x0.74x0.86x0.67x1.83x3.72x0.79x-0.30x0.23x
Cash Conversion Cycle203.44201.83250.26274.11295.06274.79351.74435.27-
Total Non-Current Liabilities65.35M106.59M233.82M129.13M119.57M133M514.67M160.21M0
Long-Term Debt14.44M54.92M188.83M86.92M72.89M73.15M73.15M29.26M0
Capital Lease Obligations57.53M14.48M14.6M17.09M14.35M0000
Deferred Tax Liabilities000000027.07K0
Other Non-Current Liabilities31.12M31.01M24.78M21.75M29.27M57.57M440.3M130.92M0
Total Liabilities409.1M594.93M563.97M532.54M371.98M308.59M698.29M356.01M75.79K
Total Debt193.04M384.49M328.89M205.18M175M147.4M151.03M150.15M75.34K
Net Debt49.96M279.52M255.88M123.17M-56.41M-333.53M129.53M150.01M57.84K
Debt / Equity0.36x0.94x0.85x0.36x0.29x0.21x-2.51x2.97x
Debt / EBITDA-85.49x5.22x-------
Net Debt / EBITDA-22.12x3.80x-------
Interest Coverage10.11x-6.05x-19.13x-39.49x-46.60x-37.16x-4.86x-8.36x-
Total Equity543.09M410.51M387.89M564.19M612.98M686.7M-293.78M59.81M25.41K
Equity Growth %31.27%5.83%-31.25%-7.96%-10.74%333.74%-591.18%--
Book Value per Share1.561.261.221.812.023.69-2.971.710.00
Total Shareholders' Equity543.09M410.51M387.89M564.19M612.98M686.7M-384.6M-20.75M25.41K
Common Stock39K34K33K32K31K30K6K6K720
Retained Earnings-1.09B-1.12B-1.09B-897.5M-791.16M-632.1M-398M-314.73M-792
Treasury Stock000000000
Accumulated OCI1.81M-11.14M-32.16M-19.58M-12.05M12.73M13.39M-9.27M0
Minority Interest00000090.82M80.56M0

Key Metrics

Growth RegimeMixed
ProfitabilityWeak
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Liquidity cushion dependent on financing

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Deleveraging Reverses Two-Year Erosion

According to Microvast's 10-Q filings, equity rebounded from a $356.1M trough in 2025Q2 to $543.1M in 2026Q2 while total debt fell from $429.1M to $193.0M, marking the sharpest balance-sheet repair in the reported ten-quarter window.

The repair is notable because it occurred alongside deepening accumulated losses and a 2026Q2 operating cash outflow of roughly $10.5M, so the improvement appears driven by financing and liability management rather than internally generated strength. Investors should treat the trajectory as balance-sheet stabilization from a low base: leverage and liquidity metrics are materially better than in 2025, but the business has yet to demonstrate that it can fund this improvement through operations.

Debt Paydown Outpaces Operating Generation

As reported in Microvast's balance sheets, total debt dropped to $193.0M in 2026Q2 from $429.1M just two quarters prior, cutting the debt-to-equity ratio to 0.36 from 1.20 and materially reducing near-term refinancing exposure over a short horizon.

The $133M reduction in debt alongside a $52.4M cash build implies that repayment was at least partly funded by capital inflows rather than free cash flow, which the prior cash flow work suggests is negative after capex. With debt at roughly 20% of the $952.2M asset base, absolute leverage no longer appears constraining, but the durability of this profile still depends on operating cash flow turning positive and sustaining.

Liquidity Rebuilt, Yet Margin Stays Thin

Based on Microvast's reported figures, the current ratio recovered to 1.09 in 2026Q2 from 0.83 in 2025Q2, with cash rising to $143.1M, yet that cushion remains narrow relative to $409.1M of reported total liabilities.

Cash has grown roughly 3.6x from $39.5M in 2024Q1, which materially reduces near-term solvency pressure for an industrial manufacturer carrying heavy plant investment. However, a current ratio only slightly above 1.0 combined with volatile working-capital swings that absorbed $17.3M in 2026Q2 suggests limited absorption capacity; a single quarter of inventory or receivable build could push the company back below breakeven current coverage.

Equity Rebuild Skips Past Retained Losses

According to SEC filings, MVST's equity stood at $543.1M in 2026Q2 while accumulated retained earnings deepened to approximately -$1.1B over the same ten-quarter window, implying the equity rebuild originates from external capital contributions rather than profit retention.

Equity is essentially flat against the $546.1M recorded in 2024Q1 despite three years of operation, meaning book value has been propped up by capital inflows offsetting roughly $180M of additional accumulated deficits. The practical implication is that reported book equity overstates self-funded value creation; quality of equity should be judged against tangible operating contribution, which the negative retained earnings balance indicates remains elusive.

Deferred Revenue Retreat Signals Softer Backlog

As detailed in Microvast's quarterly filings, deferred revenue fell to $31.7M in 2026Q2 from $47.7M in 2025Q4, a 33.6% decline that suggests customer prepayments and contracted-but-unbilled obligations are contracting rather than building, indicating reduced near-term revenue visibility.

At $31.7M against $87.3M of 2026Q2 revenue, deferred revenue still represents roughly 36% of a quarter's sales, so a meaningful履约 base exists, but the direction of travel does not corroborate a rebuilding demand story. The series has been erratic, including a $11.2M reading in 2025Q3, so investors should avoid drawing a trend from any single quarter and instead watch whether the decline persists alongside the revenue volatility identified in the income statement work.

Shrinking Plant Undercuts Asset Strength

Based on Microvast's reported balance sheets, net property, plant and equipment slid to $543.4M in 2026Q2 from $635.3M in 2024Q1 while reported total assets held near $952M, suggesting depreciation is outpacing reinvestment into domestic manufacturing capacity.

Because PPE constitutes roughly 57% of total assets, headline equity strength is largely tied to illiquid industrial plant whose book value is eroding, a pattern consistent with the lumpy capex and negative operating cash flow noted in the cash flow analysis. Investors should also verify the goodwill line, which prints $13.8M in 2025Q4, $2.1M in 2026Q1 and $13.7M in 2026Q2; though immaterial against $543.1M of equity, the volatility warrants reconciliation against filings before assuming asset carrying values are stable.

MVST — Frequently Asked Questions

Quick answers to the most common questions about buying MVST stock.

What are the total assets of Microvast Holdings, Inc. (MVST)?

As of 2025, Microvast Holdings, Inc. (MVST) had total assets of $1.01B including $448.7M in current assets.

How much debt does Microvast Holdings, Inc. (MVST) have?

Microvast Holdings, Inc. (MVST) carries total debt of $384.5M, offset by $105.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Microvast Holdings, Inc.?

Microvast Holdings, Inc. (MVST) has total shareholders' equity (book value) of $410.5M ($1.26 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Microvast Holdings, Inc.'s current ratio and liquidity?

Microvast Holdings, Inc. (MVST) reported a current ratio of 0.92x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.